... metformin 16 Role of the Adipocyte inDevelopmentofTypeDiabetes effects (Tang et al., 20 01), acting as co-adjuvants in the reduction of the incident ofdiabetes (Doggrell, 20 02) , increasing vascular ... highest insulin-dependent consumption of glucose and thus of major importance in the developmentof insulin resistance 34 Role of the Adipocyte inDevelopmentofTypeDiabetes Fig The migration of ... below), but also indicate that dynein is involved in the initial formation of the droplet (Andersson et al., 20 06) The 32 Role of the Adipocyte inDevelopmentofTypeDiabetes details of this latter...
... Curr Opin Clin Nutr Metab Care 20 02, 5:551-559 14 Marette A: Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings Curr Opin Clin Nutr Metab Care 20 02, 5:377-383 ... diagnosing diabetes mellitus J Clin Endocrinol Metab 20 08, 93 :24 47 -24 53 46 International Expert Committee report on the role of the A1C assay in the diagnosis ofdiabetesDiabetes Care 20 09, 32: 1 327 -1334 ... Manifestations of chronic disease during pregnancy Jama 20 05, 29 4 :27 51 -27 57 49 Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence oftype diabetes: a systematic review Diabetes Care 20 02, 25 :18 62- 1868...
... I enjoy 12 Insulin means my health will deteriorate 13 Injecting insulin is embarrassing 14 Injecting insulin is painful 15 It is difficult to always inject insulin correctly 16 Insulin makes ... flexible Fear of needle injection Insulin will increase the risk of hypoglycaemia Insulin will improve health Insulin will cause weight gain 10 Insulin will be demanding to administer 11 Insulin means ... diabetes The scope of the problem Diabetes Care 20 05, 28 :25 43 -25 45 Meece J: Dispelling myths and removing barriers about insulin intypediabetesDiabetes Educator 20 06, 32( 1):9S-18S Brod M, Skovlund...
... I enjoy 12 Insulin means my health will deteriorate 13 Injecting insulin is embarrassing 14 Injecting insulin is painful 15 It is difficult to always inject insulin correctly 16 Insulin makes ... flexible Fear of needle injection Insulin will increase the risk of hypoglycaemia Insulin will improve health Insulin will cause weight gain 10 Insulin will be demanding to administer 11 Insulin means ... diabetes The scope of the problem Diabetes Care 20 05, 28 :25 43 -25 45 Meece J: Dispelling myths and removing barriers about insulin intypediabetesDiabetes Educator 20 06, 32( 1):9S-18S Brod M, Skovlund...
... and well-being in relation to glycemic control intype II diabetesDiabetes Care 1996, 19 :20 4-10 21 25 26 27 28 29 Testa MA, Simonson DC: Health economic benefits and quality of life during improved ... Microalbuminuria was defined as a urine Albumin:Creatinine Ratio (ACR) ≥ 2. 5 - 25 mg/mmol in men and ≥ 3.5 - 25 mg/mmol in women Macroalbuminuria: ARC > 25 mg/mmol Peripheral neuropathy was defined ... Diabetes Educ 20 08, 34 :24 2-65 Cochran J, Conn VS: Meta-analysis of quality of life outcomes following diabetes self-management training Diabetes Educ 20 08, 34:815 -23 Van der Does FE, De Neeling...
... 20 03 to 20 52 6000 5000 20 52 number 4000 20 03 3000 20 00 1000 0 10 20 30 40 50 age [yeas] Fig 16 Number of D2 patients from 20 03 to 20 52 60 70 80 90 100 Burden ofDiabetesType Through Modelling and ... prevalence of D2 model is shown in Fig 16 3.5 x 10 number of people from 20 03 to 20 52 2003 2. 5 1.5 20 52 0.5 0 10 20 30 40 50 60 age [years] 70 80 90 100 Fig 15 Number of people in Slovenia from 20 03 ... results of their study of lifestyle interventions in preventing typediabetes Maki and Rains review existing data on how the consumption of dietary fiber can lower the risk for developmentoftype diabetes...
... CSAs in the controls were 0.08 ± 0. 02 cm2 in the MA, 0.07 ± 0. 02 cm2 in the MB, 0.04 ± 0.01 cm2 in the UA, 0.10 ± 0.03 cm2 in the TA, and 0.04 ± 0.01 cm2 in the SA The CSAs was a significant increase ... shown in Table The CSAs in the patients with DM group were 0.13 ± 0.05 cm2 in the MA, 0.09 ± 0.03 cm2 in the MB, 0.0.7 ± 0. 02 cm2 in the UA, 0.18 ± 0.04 cm2 in the TA, and 0.05 ± 0.01 cm2 in the ... Salmeron, E., Lai, J., & Unwin, DH (20 01) A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia Stroke, Vol 32, No 9, pp 20 93 -20 98,1 524 4 628 (Electronic) Wall...
... Excellence, London; 20 04 Page of (page number not for citation purposes) Journal of Foot and Ankle Research 20 08, 1:9 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Frykberg RG, ... to the Weinstein Enhanced Sensory Test J Hand Ther 1993, 6:11 -22 Bell-Krotoski J, Weinstein S, Weinstein C: Testing sensibility, including touch-pressure, two-point discrimination, point localization, ... Robbins DC: Use of the Semmes-Weinstein Monofilament in the Strong Heart Study Diabetes Care 1999, 22 :1715-1 721 Portney LG, Watkins MP: Foundations of Clinical Research Applications to Practice 2nd...
... there is a growing interest in the assessment of health-related quality of life (HRQOL) intypediabetes An increasing number oftypediabetes trials, including studies evaluating diabetes self-management ... following diabetes selfmanagement training Diabetes Educ 20 08;34:815 -23 Van der Does FE, De Neeling JN, Snoek FJ, et al Symptoms and well-being in relation to glycemic control intype II diabetesDiabetes ... Health 20 09;Early View July 25 Polonsky WH Understanding and Assessing Diabetes- Specific Quality of Life Diabetes Spectrum 20 00;13:36 26 Vinik AI, Zhang Q Adding insulin glargine versus rosiglitazone:...
... increased in obese men J Clin Endocrinol Metab 20 01, 86:1 921 -1 924 Page of (page number not for citation purposes) Theoretical Biology and Medical Modelling 20 09, 6: 12 23 24 25 26 27 http://www.tbiomed.com/content/6/1/ 12 ... metabolic syndrome, including visceral obesity, insulin resistance and dyslipidemia [25 ,26 ] In CGC, HSD11B2 is ranked tenth, obtaining 35.1 CGC points due to as much as nine matching keywords, although ... Department of Genome Sciences, University of Washington, Seattle; 20 05 Johnson JD, Misler S: Nicotinic acid- adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human...
... al Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with typediabetesDiabetes 20 02; 51 :20 74 -20 81 13 DeFronzo R, Goodman A Efficacy of metformin in patients ... glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with typediabetesDiabetes Care 20 03 ;26 :23 70 -23 77 27 Lindsay JR, Duffy ... et al Reduction in the incidence oftypediabetes with lifestyle intervention of metformin N Engl J Med 20 02; 346:393-403 21 Chan NN, Brain HP, Feher MD Metforminassociated lactic acidosis: a rare...